Diabo, Mary A.
HRN: 06-70-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/22/2025
05/29/2025
IVTT
600mg
Q6H
INFECTED WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes